Biotest AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other
companies in this sector in Germany:
Eckert & Ziegler Strahlen- und Medizinte
sales of 140.05 million Euro [US$153.73 million]
of which 48%
was Isotope Products),
(127.68 million Euro [US$140.15 million]
of which 83%
was EVT Execute), and
(229.73 million Euro [US$252.17 million]
During the year ended December of 2015, sales at
Biotest AG were 589.60 million Euro (US$647.20 million).
a very small
increase of 1.3%
versus 2014, when the company's sales were 582.00 million Euro.
This was the fifth consecutive year of sales increases at Biotest AG
(and since 2010, sales have increased a total of 43%).
Sales of Plasma and Services saw an increase
that was more than double the company's growth rate: sales were up
8.1% in 2015, from
157.00 million Euro to 169.70 million Euro.
Not all segments of Biotest AG experienced an increase in sales in 2015:
sales of Other fell 44.1% to 8.50 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).